JP2018131439A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018131439A5 JP2018131439A5 JP2018021874A JP2018021874A JP2018131439A5 JP 2018131439 A5 JP2018131439 A5 JP 2018131439A5 JP 2018021874 A JP2018021874 A JP 2018021874A JP 2018021874 A JP2018021874 A JP 2018021874A JP 2018131439 A5 JP2018131439 A5 JP 2018131439A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- patient
- composition according
- compound
- infected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/431,906 | 2017-02-14 | ||
| US15/431,906 US11484534B2 (en) | 2013-03-14 | 2017-02-14 | Methods for treating HCV |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018131439A JP2018131439A (ja) | 2018-08-23 |
| JP2018131439A5 true JP2018131439A5 (https=) | 2021-04-01 |
Family
ID=61192811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018021874A Pending JP2018131439A (ja) | 2017-02-14 | 2018-02-09 | Ｈｃｖを処置する方法 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP3360555A1 (https=) |
| JP (1) | JP2018131439A (https=) |
| CN (1) | CN108421029A (https=) |
| AU (1) | AU2018201011A1 (https=) |
| BR (1) | BR102018002956A2 (https=) |
| CA (1) | CA2994496A1 (https=) |
| MX (1) | MX2018001905A (https=) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005058821A1 (en) * | 2003-12-11 | 2005-06-30 | Schering Corporation | Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| US9394279B2 (en) | 2009-06-11 | 2016-07-19 | Abbvie Inc. | Anti-viral compounds |
| JP5857053B2 (ja) | 2010-09-21 | 2016-02-10 | エナンタ ファーマシューティカルズ インコーポレイテッド | 大環式プロリン由来ｈｃｖセリンプロテアーゼ阻害剤 |
| DE202012012955U1 (de) | 2011-10-21 | 2014-07-14 | Abbvie Inc. | Eine Kombination aus mindestens zwei direkt wirkenden antiviralen Wirkstoffen (DAAs) für die Verwendung zur Behandlung von HCV |
| EP2583677A3 (en) * | 2011-10-21 | 2013-07-03 | Abbvie Inc. | Methods for treating HCV comprising at least two direct acting antiviral agent, ribavirin but not interferon. |
| KR20210013344A (ko) * | 2013-03-14 | 2021-02-03 | 애브비 인코포레이티드 | C형 간염 치료용 2가지 항바이러스제의 병용물 |
| JP6563894B2 (ja) * | 2013-03-14 | 2019-08-21 | アッヴィ・インコーポレイテッド | Ｈｃｖ患者を治療するための直接的に作用する抗ウイルス剤とリバビリンとの併用 |
| US10286029B2 (en) * | 2013-03-14 | 2019-05-14 | Abbvie Inc. | Method for treating HCV |
| JP6808660B2 (ja) * | 2015-07-08 | 2021-01-06 | アッヴィ・インコーポレイテッド | Ｈｃｖを処置するための方法 |
-
2018
- 2018-02-09 JP JP2018021874A patent/JP2018131439A/ja active Pending
- 2018-02-09 CA CA2994496A patent/CA2994496A1/en active Pending
- 2018-02-12 AU AU2018201011A patent/AU2018201011A1/en not_active Abandoned
- 2018-02-12 EP EP18156337.0A patent/EP3360555A1/en not_active Withdrawn
- 2018-02-13 CN CN201810149405.XA patent/CN108421029A/zh active Pending
- 2018-02-14 MX MX2018001905A patent/MX2018001905A/es unknown
- 2018-02-15 BR BR102018002956A patent/BR102018002956A2/pt not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2002120922A (ru) | Нуклеозидные аналоги с карбоксамидин-модифицированным моноциклическим основанием | |
| JP2004509061A5 (https=) | ||
| JP2021521118A5 (https=) | ||
| JP2014530874A5 (https=) | ||
| JP2009535352A5 (https=) | ||
| JP2011519364A5 (https=) | ||
| JP2021100937A5 (https=) | ||
| JP2016513703A5 (https=) | ||
| JP2013522302A5 (https=) | ||
| RU2010113976A (ru) | Применение glp-1 в качестве терапевтического средства | |
| JP2003526662A5 (https=) | ||
| JP2004534769A5 (https=) | ||
| RU2010114047A (ru) | Применение нейропептида af человека в качестве терапевтического средства | |
| SI2968302T1 (en) | Combination of directly-acting antiviral agents and ribavarin for the treatment of patients with HCV | |
| RU2011127080A (ru) | Производное циклоспорина для применения в лечении заражения вирусом гепатита с и вич | |
| RU2015114543A (ru) | Способы лечения гепатита с | |
| RU2005126412A (ru) | Сор1 для лечения воспалительных заболеваний кишечника | |
| RU2012136824A (ru) | Способы лечения вирусной инфекции гепатита с | |
| JP2013518124A5 (https=) | ||
| CN102083435A (zh) | 特拉匹韦给药方案 | |
| JP2022551691A5 (https=) | ||
| NZ588655A (en) | Treatment of hepatitis c virus infections with telaprevir (vx-950) in patients non-responsive to treatment with pegylated interfer0n-alpha-2a/2b and ribavirin | |
| RU2002112248A (ru) | Лечение вирусных инфекций с использованием левовирина | |
| JP2018131439A5 (https=) | ||
| JP2021523129A5 (https=) |